John H. Duerden

This profile gathers the share dealings of John H. Duerden across 2 companies, led by Obagi Medical Products, Inc. and Crocs, Inc. The record holds 9 filings, for trades running from 12 December 2007 to 25 April 2013.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

On 29 April 2013 came the latest disclosure, a transaction for €41k in Obagi Medical Products, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.